# GDOC holdings: all 41 positions

> All 41 GDOC holdings with weights, as of May 31, 2026. The top 3 are LLY 13.28%, JNJ 8.07% and MRK 5.94%. Download the full list as a CSV.

Data as of May 31, 2026. Rebuilt every trading night.

GDOC held 41 positions as of May 31, 2026. Eli Lilly & Co is the largest at 13.28%; the top 10 are 57.3% of the fund.

Source: Form N-PORT filed with the SEC (https://www.sec.gov/Archives/edgar/data/1479026/000094040026028080/primary_doc.xml).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Eli Lilly & Co | LLY | 13.28% |
| 2 | Johnson & Johnson | JNJ | 8.07% |
| 3 | Merck & Co Inc | MRK | 5.94% |
| 4 | Guardant Health Inc | GH | 5.34% |
| 5 | Astrazeneca PLC | AZN | 4.84% |
| 6 | Thermo Fisher Scientific Inc | TMO | 4.52% |
| 7 | Argenx SE | ARGX | 4.07% |
| 8 | Intuitive Surgical Inc | ISRG | 3.90% |
| 9 | Boston Scientific Corp | BSX | 3.78% |
| 10 | Hoya Corp | 7741 | 3.53% |
| 11 | Edwards Lifesciences Corp | EW | 2.98% |
| 12 | Lonza Group AG | LONN | 2.80% |
| 13 | Dexcom Inc | DXCM | 2.79% |
| 14 | Agilent Technologies Inc | A | 2.77% |
| 15 | Roivant Sciences Ltd | ROIV | 2.39% |
| 16 | Cencora Inc | COR | 2.34% |
| 17 | Apogee Therapeutics Inc | APGE | 1.97% |
| 18 | Royalty Pharma PLC | RPRX | 1.77% |
| 19 | Penumbra Inc | PEN | 1.61% |
| 20 | Mettler-Toledo International Inc | MTD | 1.59% |
| 21 | Vertex Pharmaceuticals Inc | VRTX | 1.48% |
| 22 | Cytokinetics Inc | CYTK | 1.40% |
| 23 | Ionis Pharmaceuticals Inc | IONS | 1.37% |
| 24 | Xenon Pharmaceuticals Inc | XENE | 1.35% |
| 25 | UnitedHealth Group Inc | UNH | 1.35% |
| | Cash and other net assets | | 1.52% |

The largest 25 of 41 positions are shown. All of them: https://etfiq.com/funds/gdoc/holdings/gdoc-holdings.csv (CSV) or https://etfiq.com/data/books/gdoc.json (JSON).

Fund page: https://etfiq.com/funds/gdoc

Cite: ETFIQ, Holdings of GDOC, data as of May 31, 2026. https://etfiq.com/funds/gdoc/holdings/